General Vaccine Information
With the COVID-19 global pandemic, we are facing the greatest public health crisis in more than one hundred years. Adherence to appropriate health and safety guidance and widespread vaccination is our best hope of controlling the pandemic and further loss of lives.
Although the COVID-19 Vaccine is not a university-required immunization, we strongly encourage you to receive the vaccine when it is available to you.
The federal government is funding and coordinating the development of multiple vaccine candidates, several of which are in large-scale (Phase 3) trials or have received Emergency Use Authorization (EUA) through the Food and Drug Administration (FDA). It is important to note that throughout this process, COVID-19 vaccines are being held to the same safety standards as all other vaccines.
Your decision to accept or reject the vaccine should be based on reliable information. We encourage you to seek answers to your questions regarding the vaccine from trusted sources such as your healthcare provider or the Centers for Disease Control and Prevention (CDC). The CDC has posted answers to frequently asked questions about the COVID-19 vaccines on their website.
State of Tennessee Vaccine Plan and Eligibility
As outlined in the State of Tennessee’s Vaccine Plan, the Tennessee Department of Health (TDOH), in coordination with regional health experts, has determined the manner in which the vaccine may be distributed and administered.
On-campus COVID-19 Vaccine Availability and Scheduling:
Johnson & Johnson (Janssen) Vaccine
Johnson & Johnson’s Janssen vaccine is a single-dose vaccine. Recipients are considered fully vaccinated two weeks after receiving the shot. According to the FDA and CDC, women younger than 50 years old should be aware of the rare risk of blood clots with low platelets after receiving this vaccine. Other COVID-19 vaccines are available where this risk has not been seen.
People who have received the Johnson & Johnson (Janssen) vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider.
If you have questions regarding the Johnson & Johnson’s Janssen vaccine or its risks, please speak with a health care provider before receiving the vaccine.
The University of Tennessee will continue to serve as a distribution site for the Moderna COVID-19 vaccine. The Moderna vaccine is a two dose vaccine separated by 28 days. Two doses of this vaccine are required in order to be considered fully vaccinated.
The University will publicly post information about our on-campus vaccination opportunities. This information will be posted at the university’s COVID website as well as through UT publications such as Tennessee Today and Vol Update. Information regarding these opportunities will include sign-up links.
Vaccine appointments will not be available for scheduling through the SHC Appointment Line nor the SHC Patient Portal. Please do not contact the SHC to schedule a COVID-19 vaccine appointment.
Vaccine sites will also be available through other community resources as well as the Knox County Health Department (KCHD) or local retail outlets.